Last Updated on October 17, 2024 by The Health Master
Unichem Laboratories has received tentative approval for ANDA of Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (USFDA)
This approval is for a generic version of Januvia (sitagliptin) tablets, 25 mg, 50 mg, and 100 mg, of Merck Sharpe and Dohme Corp (Merck).
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The product will be commercialised from Unichem’s Goa Plant on receipt of full approval.
Alembic gets USFDA final nod for Erlotinib Tablets
Alembic gets USFDA nod for drug for the treatment of Depression
USFDA approves Abbott’s Stent to treat high bleeding risk patients
Zydus Cadila gets USFDA nod for drug to treat HIV infection
Alembic gets USFDA nod for Nitrofurantoin Capsules USP
Axio Biosolution gets USFDA nod for Patch for bleeding control
All Legislation of India (for Pharma and Health professionals)
Latest Notifications: General (Pharmaceuticals)
Webinar held on Investigational skills for Drug regulators of India
CDSCO to API units: To file online applications on Sugam Portal
Delhi High Court set up IPD for Pharma Industry
Fake Favipiravir racket busted: FIR lodged
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
